Cases & Deals

  • Home
  • Practices
  • Takeda acquires Ariad Pharmaceuticals for $5.2 billion

Share

Takeda acquires Ariad Pharmaceuticals for $5.2 billion

February 2017

Client(s) Takeda Pharmaceuticals U.S.A., Inc.

Jones Day advised Takeda Pharmaceuticals U.S.A., Inc. on intellectual property matters relating to its $5.2 billion acquisition of Ariad Pharmaceuticals.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.